Literature DB >> 16824033

Current and future molecular diagnostics for prion diseases.

Marty T Lehto1, Harry E Peery, Neil R Cashman.   

Abstract

It is now widely held that the infectious agents underlying the transmissible spongiform encephalopathies are prions, which are primarily composed of a misfolded, protease-resistant isoform of the host prion protein. Untreatable prion disorders include some human diseases, such as Creutzfeldt-Jakob disease, and diseases of economically important animals, such as bovine spongiform encephalopathy (cattle) and chronic wasting disease (deer and elk). Detection and diagnosis of prion disease (and presymptomatic incubation) is contingent upon developing novel assays, which exploit properties uniquely possessed by this misfolded protein complex, rather than targeting an agent-specific nucleic acid. This review highlights some of the conventional and disruptive technologies developed to respond to this challenge.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824033     DOI: 10.1586/14737159.6.4.597

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  3 in total

1.  Mechanistic insights into the cure of prion disease by novel antiprion compounds.

Authors:  Sarah Webb; Tamuna Lekishvili; Corinna Loeschner; Shane Sellarajah; Frances Prelli; Thomas Wisniewski; Ian H Gilbert; David R Brown
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

2.  Using small molecule reagents to selectively modify epitopes based on their conformation.

Authors:  Christopher J Silva
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

3.  The identification of disease-induced biomarkers in the urine of BSE infected cattle.

Authors:  Sharon L R Simon; Lise Lamoureux; Margot Plews; Michael Stobart; Jillian LeMaistre; Ute Ziegler; Catherine Graham; Stefanie Czub; Martin Groschup; J David Knox
Journal:  Proteome Sci       Date:  2008-09-05       Impact factor: 2.480

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.